focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,172.00
Bid: 12,168.00
Ask: 12,170.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.016%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,172.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Debenhams Raised After Strong Report

Fri, 17th Apr 2015 08:58

LONDON (Alliance News) - The following shares received analyst recommendations Friday morning:
---------
FTSE 100
----------
CANACCORD RAISES SMITHS GROUP PRICE TARGET TO 1410 (1390) PENCE - 'HOLD'
----------
EXANE BNP RAISES SMITHS GROUP PRICE TARGET TO 1150 (1050) PENCE - 'NEUTRAL'
----------
NOMURA RAISES SMITHS GROUP PRICE TARGET TO 1400 (1320) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES SMITHS GROUP PRICE TARGET TO 1520 (1310) PENCE - 'OVERWEIGHT'
----------
EXANE BNP RAISES WEIR GROUP PRICE TARGET TO 1925 (1500) PENCE
----------
EXANE BNP RAISES WEIR GROUP TO 'NEUTRAL' ('UNDERPERFORM')
----------
EXANE BNP CUTS GKN TO 'NEUTRAL' ('OUTPERFORM') - TARGET 380 PENCE
----------
CREDIT SUISSE RAISES WHITBREAD PRICE TARGET TO 6200 (5300) PENCE - 'OUTPERFORM'
----------
CANACCORD RAISES KINGFISHER PRICE TARGET TO 334 (300) PENCE - 'HOLD'
----------
CANACCORD RAISES DIAGEO PRICE TARGET TO 1515 (1465) PENCE - 'SELL'
----------
JPMORGAN RAISES UNILEVER PLC PRICE TARGET TO 2900 (2750) PENCE - 'UNDERWEIGHT'
----------
Liberum Raises Unilever Price Target To 2,400p From 2,310p, Reiterates Sell
----------
JPMORGAN RAISES SABMILLER PRICE TARGET TO 4000 (3650) PENCE - 'OVERWEIGHT'
----------
UBS RAISES SABMILLER PRICE TARGET TO 3600 (3500) PENCE - 'NEUTRAL'
----------
BERENBERG RAISES SABMILLER PRICE TARGET TO 3920 (3700) PENCE - 'BUY'
----------
Berenberg Raises SABMiller Price Target To 3,920p From 3,700p, Reiterates Buy
----------
DAVY INITIATES ROYAL MAIL WITH 'UNDERPERFORM' - TARGET 380 PENCE
----------
GOLDMAN RAISES MEGGITT PRICE TARGET TO 592 (573) PENCE - 'NEUTRAL'
----------
GOLDMAN RAISES BAE SYSTEMS PRICE TARGET TO 611 (577) PENCE - 'BUY'
----------
DEUTSCHE BANK RAISES ASTRAZENECA PRICE TARGET TO 4850 (4800) PENCE - 'HOLD'
----------
DEUTSCHE BANK RAISES SHIRE PRICE TARGET TO 5900 (5700) PENCE - 'BUY'
----------
FTSE 250
----------
EXANE BNP RAISES MELROSE INDUSTRIES TARGET TO 315 (300) PENCE - 'OUTPERFORM'
----------
CANACCORD CUTS PETRA DIAMONDS PRICE TARGET TO 220 (230) PENCE - 'BUY'
----------
EXANE BNP CUTS VESUVIUS PRICE TARGET TO 515 (540) PENCE - 'OUTPERFORM'
----------
EXANE BNP RAISES SPIRAX-SARCO PRICE TARGET TO 3550 (3500) PENCE - 'NEUTRAL'
----------
EXANE BNP CUTS ROTORK PRICE TARGET TO 2600 (2610) PENCE - 'NEUTRAL'
----------
BARCLAYS CUTS ROTORK TO 'EQUAL WEIGHT' ('OVERWEIGHT')
----------
EXANE BNP RAISES IMI PRICE TARGET TO 1150 (1100) PENCE - 'UNDERPERFORM'
----------
EXANE BNP RAISES HALMA PRICE TARGET TO 800 (780) PENCE - 'OUTPERFORM'
----------
EXANE BNP RAISES SPECTRIS TO 'NEUTRAL' ('UNDERPERFORM') - TARGET 2375 (1850) PENCE
----------
BARCLAYS RAISES SPECTRIS PRICE TARGET TO 2535 (2065) PENCE - 'OVERWEIGHT'
----------
CREDIT SUISSE RAISES JUPITER FUND PRICE TARGET TO 430 (378) PENCE - 'NEUTRAL'
----------
MORGAN STANLEY RAISES PLAYTECH PRICE TARGET TO 1030 (960) PENCE - 'OVERWEIGHT'
----------
JPMORGAN CUTS CARILLION PRICE TARGET TO 305 (330) PENCE - 'NEUTRAL'
----------
PANMURE RAISES PROVIDENT FINANCIAL PRICE TARGET TO 3000 (2700) PENCE - 'HOLD'
----------
SOCGEN RAISES DEBENHAMS PRICE TARGET TO 80 (67) PENCE - 'HOLD'
----------
UBS RAISES DEBENHAMS PRICE TARGET TO 90 (85) PENCE - 'BUY'
----------
CITIGROUP RAISES DEBENHAMS TO 'BUY' ('NEUTRAL') - TARGET 95 (75) PENCE
----------
BARCLAYS RAISES MORGAN ADVANCED MATERIALS TARGET TO 350 (305) PENCE - 'EQUALWEIGHT'
----------
BARCLAYS RAISES LAIRD PRICE TARGET TO 370 (315) PENCE - 'EQUAL WEIGHT'
----------
BARCLAYS RAISES IMI PRICE TARGET TO 1380 (1340) PENCE - 'EQUAL WEIGHT'
----------
BARCLAYS RAISES HALMA PRICE TARGET TO 715 (650) PENCE - 'EQUAL WEIGHT'
----------
BARCLAYS CUTS DOMINO PRINTING TO 'EQUAL WEIGHT' ('OVERWEIGHT')
----------
BARCLAYS RAISES DOMINO PRINTING PRICE TARGET TO 915 (730) PENCE
----------
BARCLAYS RAISES RENISHAW PRICE TARGET TO 2825 (2425) PENCE - 'OVERWEIGHT'
----------
GOLDMAN RAISES QINETIQ PRICE TARGET TO 208 (204) PENCE - 'NEUTRAL'
----------
BARCLAYS RAISES QINETIQ TO 'OVERWEIGHT' ('EQUAL WEIGHT') - TARGET 220 (210) PENCE
----------
BARCLAYS INITIATES MONEYSUPERMARKET WITH 'OVERWEIGHT' - TARGET 315 PENCE
----------
TRADERS: HSBC RAISES PENNON GROUP PRICE TARGET TO 970 (960) PENCE
----------
GOLDMAN CUTS ULTRA ELECTRONICS PRICE TARGET TO 1833 (2011) PENCE - 'NEUTRAL'
----------
GOLDMAN RESUMES COBHAM WITH 'NEUTRAL' - TARGET 329 PENCE
----------
GOLDMAN CUTS PETROFAC TO 'BUY' ('CONVICTION BUY LIST') - TARGET 1130 PENCE
----------
GOLDMAN RAISES HUNTING TO 'CONVICTION BUY' ('BUY') - TARGET 709 (622) PENCE
----------
MAIN MARKET AND AIM
----------
CANACCORD RAISES ONESAVINGS BANK TO 'BUY' ('HOLD') - TARGET 316 (290) PENCE
----------
JPMORGAN CUTS MOTHERCARE PRICE TARGET TO 235 (239) PENCE - 'OVERWEIGHT'
----------
JPMORGAN INITIATES URBAN & CIVIC WITH 'NEUTRAL' - TARGET 300 PENCE
----------
Cantor Fitzgerald Raises Chariot Oil & Gas Price Target To 20p From 12p, Reiterates Buy
----------
BARCLAYS RAISES OXFORD INSTRUMENTS PRICE TARGET TO 1000 (860) PENCE
----------
BARCLAYS RAISES OXFORD INSTRUMENTS TO 'OVERWEIGHT' ('EQUAL WEIGHT')
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
27 Dec 2023 17:02

LONDON MARKET CLOSE: Stocks start week higher as 2024 draws to close

(Alliance News) - Equities in London kicked off an abbreviated trading week with gains on Wednesday, on continued US interest rate optimism at the end of 2024.

Read more
27 Dec 2023 14:25

London close: Stocks maintain gains amid post-Christmas rally

(Sharecast News) - London's stock markets closed in positive territory on Wednesday, buoyed by a global surge in stock prices as the S&P 500 neared an all-time high on Wall Street.

Read more
27 Dec 2023 12:06

LONDON MARKET MIDDAY: Stocks hold onto gains amid US rate cut hopes

(Alliance News) - London's FTSE 100 index was outperforming other European stock-price measures at midday on Wednesday, boosted by gains for miners and industrials.

Read more
27 Dec 2023 11:20

London midday: Stocks ride global wave of post-Christmas optimism

(Sharecast News) - London's equity markets were still above the waterline at lunchtime on Wednesday, following a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:48

LONDON MARKET OPEN: FTSE 100 gains led by miners and industrials

(Alliance News) - Stock prices in London opened in the green on Wednesday, as hopes for US interest rate cuts in the new year continued to propel global equities higher.

Read more
27 Dec 2023 08:26

London open: FTSE takes cues from Wall Street 'Santa rally'

(Sharecast News) - London's stocks returned from the Christmas break in the green on Wednesday, boosted by a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:24

TOP NEWS: AstraZeneca buys Gracell to "enrich" cell therapy pipeline

(Alliance News) - AstraZeneca PLC on Tuesday said it has agreed to acquire Gracell Biotechnologies Inc, paying about USD1.2 billion for the clinical-stage company.

Read more
27 Dec 2023 07:52

LONDON BRIEFING: AstraZeneca buys Gracell Biotech; COPL CEO resigns

(Alliance News) - Stocks in London were expected to make gains at Wednesday's market open, as investors continued to pin their hopes on US interest rate cuts.

Read more
27 Dec 2023 07:02

AstraZeneca to buy Gracell Technologies for $1.2bn

(Sharecast News) - AstraZeneca on Wednesday said it was buying Gracell Biotechnologies, a global clinical-stage biopharmaceutical company developing cell therapies for the treatment of cancer and autoimmune diseases, for $1.2bn.

Read more
26 Dec 2023 21:26

Wall Street ends higher in final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more
26 Dec 2023 21:00

Wall Street ends higher in final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more
26 Dec 2023 19:41

Wall Street gains on final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more
22 Dec 2023 08:47

AstraZeneca, Ionis get US FDA nod for Wainua in "important milestone"

(Alliance News) - AstraZeneca PLC and Ionis Pharmaceuticals Inc on Friday celebrated the news that their drug eplontersen was approved by the US Food & Drug Administration.

Read more
22 Dec 2023 07:50

LONDON BRIEFING: UK on brink of recession as economy contracts in Q3

(Alliance News) - Stocks in London are likely to open lower on Friday, with investors feeling frosty ahead of a US inflation print this afternoon, amid sobering UK economic growth data.

Read more
22 Dec 2023 07:17

AstraZeneca gets FDA green light for nerve disease treatment

(Sharecast News) - The US Food and Drug Administration has approved the Wainua nerve disease treatment jointly developed by AstraZeneca and Ionis Pharmaceuticals.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.